|
FAM122B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.139200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.392400E-01 |
| Normal-vs-Stage2 |
8.154000E-01 |
| Normal-vs-Stage3 |
6.082200E-01 |
| Normal-vs-Stage4 |
6.354800E-01 |
| Stage1-vs-Stage2 |
5.568600E-01 |
| Stage1-vs-Stage3 |
9.151200E-01 |
| Stage1-vs-Stage4 |
3.456200E-01 |
| Stage2-vs-Stage3 |
5.191400E-01 |
| Stage2-vs-Stage4 |
8.748600E-01 |
| Stage3-vs-Stage4 |
3.479800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.704000E-01 |
| Normal-vs-AfricanAmerican |
9.646800E-01 |
| Normal-vs-Asian |
6.239600E-01 |
| Caucasian-vs-AfricanAmerican |
7.919400E-01 |
| Caucasian-vs-Asian |
6.274200E-01 |
| AfricanAmerican-vs-Asian |
6.987600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.915800E-01 |
| Normal-vs-Female |
5.653600E-01 |
| Male-vs-Female |
4.382800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.351400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.231600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.939200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.403500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.649360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.641600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.422600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.074600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.015610E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.271600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.688000E-01 |
| Normal-vs-Grade 2 |
6.338600E-01 |
| Normal-vs-Grade 3 |
2.208800E-01 |
| Normal-vs-Grade 4 |
7.984600E-01 |
| Grade 1-vs-Grade 2 |
7.109000E-01 |
| Grade 1-vs-Grade 3 |
5.592200E-01 |
| Grade 1-vs-Grade 4 |
8.721400E-01 |
| Grade 2-vs-Grade 3 |
4.236400E-02 |
| Grade 2-vs-Grade 4 |
5.111400E-01 |
| Grade 3-vs-Grade 4 |
5.693600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.406800E-01 |
| Normal-vs-ccB subtype |
6.763200E-01 |
| ccA subtype-vs-ccB subtype |
2.841600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.830800E-01 |
| Normal-vs-N1 |
4.207800E-01 |
| N0-vs-N1 |
5.281000E-01 |
|
|
